Orally administered therapeutic agents need to cross the mucosal epithelial membrane in the \nintestine to reach the systemic circulation. This intestinal epithelial membrane is covered by a \nbiopolymer barrier, namely, mucus which protects the underlying layer through trapping or \ndegrading of foreign particles and macromolecules. Thus, mucus can restrict the systemic \nabsorption of some therapeutic agents such as peptides by enzymatic degradation. Nanoparticles \n(NPs) could serve as a carrier for these peptides to protect them from environmental conditions \nin the mucus and to increase their bioavailability. However, these NPs can be trapped \nthemselves by the mucus, hence, a proper nano-strategy should be selected to deliver these \npeptides orally. NPs delivery through intestinal mucus barrier has been studied extensively, \nwhere various in vitro tests and mucus models were investigated to mimic the in vivo test. In \nthis thesis, two mucus models were assessed for their suitability as intestinal mucus barrier \nthrough which NPs diffusion can be studied. Also, multiple particle tracking (MPT) technique \nwas exploited to study the diffusion and interaction of nanoparticles through pig intestinal \nmucus barrier. This technique (MPT) was used to understand the factors affecting the diffusion \nthrough mucus of NPs representing various nano-strategies such as PEGylated NPs and \nmucolytic NPs. Based on data obtained for the diffusion of NPs, we adopted a nano-strategy \nmimicking the capsid shell virus in which the NPs surfaces are densely covered with oppositely \ncharged groups but with overall neutral charge. To do so, polyelectrolyte (PEC) NPs based on \nthe self-assembly of (+) chitosan and (-) polyacrylic acid (PAA) were synthesized and the \ndiffusion of these densely charged NPs was studied. After proving the concept, RAFT technique \nwas used to synthesize zwitterionic densely charged NPs in which butyl methcrylate (BMA) \nwas used as the lipophilic core and sulfobetaine as the shell of NPs. \nNative mucus prepared by our group was found to be a proper model to study NPs diffusion \nthrough it by the MPT technique. Study of diffusion of NPs representing various nano-strategies \nthrough mucus revealed the impact of various properties of these NPs on their diffusion. For \nexample, particle size, zeta potential, type and molecular weight of the polymer, type and \nconcentration of the diffusion enhancer and method of synthesis of NPs were detected to affect \nthe diffusion of these NPs. For PEC NPs, the data obtained showed a relation between the zeta \npotential of NPs and their diffusivities through the mucus, where the highest diffusivity was \nobtained for the neutrally charged PEC NPs. Accordingly, sulfobetaine NPs were highly \nefficient NPs in term of their stability, charge density, particle size and importantly their \ndiffusivities through the mucus barrier which was significantly higher as compared with all \nother tested NPs and related to the ratio of the sulfobetaine polymer in the NPs. This indicates \nthat densely charged viral like NPs can be promising carriers to improve the mucus permeation \nof some therapeutic agents.